Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Patent Reform Act of 2009
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
Patent Reform Act of 2009
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C via SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
2009 · fourth_quarter · 4T
Legislative proposals that would incrase the Medicaid drug price rebate. (none yet introduced in this Congress)
S.260. Legislative proposals regarding taxation of income of US corporations earned overseas: S.260.
Source: Senate LDA
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
Patent Reform Act of 2009
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
Patent Reform Act of 2009
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
Patent Reform Act of 2009
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009. Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009. Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009. Response to congressional investigation regarding ENHANCE study.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009. Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009. Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009. Response to congressional investigation regarding ENHANCE study.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009. Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009. Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009. Response to congressional investigation regarding ENHANCE study.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009. Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009. Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009. Response to congressional investigation regarding ENHANCE study.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009. Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009. Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009. Response to congressional investigation regarding ENHANCE study.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
Pathway for Biosimilars Act
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
Pathway for Biosimilars Act
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
Pathway for Biosimilars Act
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
Pathway for Biosimilars Act
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
Pathway for Biosimilars Act
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
America's Affordable Health Choices Act of 2009
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
America's Affordable Health Choices Act of 2009
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
America's Affordable Health Choices Act of 2009
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
America's Affordable Health Choices Act of 2009
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
Food and Drug Administration Globalization Act of 2009
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009. Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009. Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009. Response to congressional investigation regarding ENHANCE study.
Food and Drug Administration Globalization Act of 2009
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009. Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009. Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009. Response to congressional investigation regarding ENHANCE study.
Food and Drug Administration Globalization Act of 2009
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009. Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009. Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009. Response to congressional investigation regarding ENHANCE study.
Food and Drug Administration Globalization Act of 2009
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009. Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009. Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009. Response to congressional investigation regarding ENHANCE study.
Food and Drug Administration Globalization Act of 2009
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009. Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009. Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009. Response to congressional investigation regarding ENHANCE study.
A bill to amend the Internal Revenue Code of 1986 to provide for the taxation of income of controlled foreign corporations attributable to imported property.
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
S.260. Legislative proposals regarding taxation of income of US corporations earned overseas: S.260.
A bill to amend the Internal Revenue Code of 1986 to provide for the taxation of income of controlled foreign corporations attributable to imported property.
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
S.260. Legislative proposals regarding taxation of income of US corporations earned overseas: S.260.
A bill to amend the Internal Revenue Code of 1986 to provide for the taxation of income of controlled foreign corporations attributable to imported property.
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
S.260. Legislative proposals regarding taxation of income of US corporations earned overseas: S.260.
A bill to amend the Internal Revenue Code of 1986 to provide for the taxation of income of controlled foreign corporations attributable to imported property.
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
S.260. Legislative proposals regarding taxation of income of US corporations earned overseas: S.260.
A bill to amend the Internal Revenue Code of 1986 to provide for the taxation of income of controlled foreign corporations attributable to imported property.
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
S.260. Legislative proposals regarding taxation of income of US corporations earned overseas: S.260.
Preserve Access to Affordable Generics Act
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
Preserve Access to Affordable Generics Act
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
Preserve Access to Affordable Generics Act
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
Preserve Access to Affordable Generics Act
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
Preserve Access to Affordable Generics Act
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
Patent Reform Act of 2009
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
Patent Reform Act of 2009
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
Patent Reform Act of 2009
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
Patent Reform Act of 2009
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
Patent Reform Act of 2009
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009. Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009. Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009. Response to congressional investigation regarding ENHANCE study.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009. Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009. Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009. Response to congressional investigation regarding ENHANCE study.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009. Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009. Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009. Response to congressional investigation regarding ENHANCE study.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009. Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009. Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009. Response to congressional investigation regarding ENHANCE study.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009. Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009. Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009. Response to congressional investigation regarding ENHANCE study.
Patent Reform Act of 2009
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
Patent Reform Act of 2009
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
Patent Reform Act of 2009
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
Patent Reform Act of 2009
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
Patent Reform Act of 2009
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
To redesignate the Ellis Island Library on the third floor of the Ellis Island Immigration Museum, located on Ellis Island in New York Harbor, as the "Bob Hope Memorial Library".
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009. Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009. Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009. Response to congressional investigation regarding ENHANCE study.
To redesignate the Ellis Island Library on the third floor of the Ellis Island Immigration Museum, located on Ellis Island in New York Harbor, as the "Bob Hope Memorial Library".
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009. Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009. Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009. Response to congressional investigation regarding ENHANCE study.
To redesignate the Ellis Island Library on the third floor of the Ellis Island Immigration Museum, located on Ellis Island in New York Harbor, as the "Bob Hope Memorial Library".
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009. Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009. Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009. Response to congressional investigation regarding ENHANCE study.
To redesignate the Ellis Island Library on the third floor of the Ellis Island Immigration Museum, located on Ellis Island in New York Harbor, as the "Bob Hope Memorial Library".
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009. Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009. Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009. Response to congressional investigation regarding ENHANCE study.
To redesignate the Ellis Island Library on the third floor of the Ellis Island Immigration Museum, located on Ellis Island in New York Harbor, as the "Bob Hope Memorial Library".
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009. Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009. Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009. Response to congressional investigation regarding ENHANCE study.
Access to Life-Saving Medicine Act
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1038, Access to Life-Saving Medicine Act; H.R.1908, Patent Reform Act of 2007; H.R.5629, Pathway for Biosimilars Act; S.316, Preserve Access to Affordable Generics Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1145, Patent Reform Act of 2007; S.1505, Affordable Biologics for Consumers Act. Legislative proposals effecting US patent system: H.R.1908, Patent Reform Act of 2007; S.1145, Patent Reform Act of 2007. Legislative proposals regarding follow-on biologics: H.R.1038, Access to Life-Saving Medicine Act; H.R.5629, Pathway for Biosimilars Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1505, Affordable Biologics for Consumers Act. Legislative proposals regarding brand-generic drug firm agreements: S.316, Preserve Access to Affordable Generics Act.
Access to Life-Saving Medicine Act
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1038, Access to Life-Saving Medicine Act; H.R.1908, Patent Reform Act of 2007; H.R.5629, Pathway for Biosimilars Act; S.316, Preserve Access to Affordable Generics Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1145, Patent Reform Act of 2007; S.1505, Affordable Biologics for Consumers Act. Legislative proposals effecting US patent system: H.R.1908, Patent Reform Act of 2007; S.1145, Patent Reform Act of 2007. Legislative proposals regarding follow-on biologics: H.R.1038, Access to Life-Saving Medicine Act; H.R.5629, Pathway for Biosimilars Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1505, Affordable Biologics for Consumers Act. Legislative proposals regarding brand-generic drug firm agreements: S.316, Preserve Access to Affordable Generics Act.
Access to Life-Saving Medicine Act
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1038, Access to Life-Saving Medicine Act; H.R.1908, Patent Reform Act of 2007; H.R.5629, Pathway for Biosimilars Act; S.316, Preserve Access to Affordable Generics Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1145, Patent Reform Act of 2007; S.1505, Affordable Biologics for Consumers Act; S.3463, A bill to amend the trade Act of 1974; S.3600, A bill to amend Title 35 US Code. Legislative proposals effecting US patent system: H.R.1908, Patent Reform Act of 2007; S.1145, Patent Reform Act of 2007; S.3463, A bill to amend the Trade Act of 1974 to improve the international protection and enforcement of intellectual property rights, and for other purposes; S.3600, A bill to amend title 35 US Code, to provide for patent reforms. Legislative proposals regarding follow-on biologics: H.R.1038, Access to Life-Saving Medicine Act; H.R.5629, Pathway for Biosimilars Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1505, Affordable Biologics for Consumers Act. Legislative proposals regarding brand-generic drug firm agreements: S.316, Preserve Access to Affordable Generics Act.
Access to Life-Saving Medicine Act
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1038, Access to Life-Saving Medicine Act; H.R.1908, Patent Reform Act of 2007; H.R.5629, Pathway for Biosimilars Act; S.316, Preserve Access to Affordable Generics Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1145, Patent Reform Act of 2007; S.1505, Affordable Biologics for Consumers Act. Legislative proposals effecting US patent system: H.R.1908, Patent Reform Act of 2007; S.1145, Patent Reform Act of 2007. Legislative proposals regarding follow-on biologics: H.R.1038, Access to Life-Saving Medicine Act; H.R.5629, Pathway for Biosimilars Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1505, Affordable Biologics for Consumers Act. Legislative proposals regarding brand-generic drug firm agreements: S.316, Preserve Access to Affordable Generics Act.
Shareholder Vote on Executive Compensation Act
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.2, Fair Minimum Wage Act of 2007; H.R.976, Children's Health Insurance Program Reauthorization Act of 2007; H.R.1257, Shareholder Vote on Executive Compensation Act; H.R.4854, False Claims Act Correction Act of 2007; S.2401, False Claims Act Correction Act of 2007. Legislative proposals regarding shareholder participation in corporate executive compensation decisons: H.R.2, Fair Minimum Wage Act of 2007; H.R.976, Children's Health Insurance Program Reauthorization Act of 2007; H.R.1257, Shareholder Vote on Executive Compensation Act. Legislation to amend the Federal False Claims Act: H.R.4854, False Claims Act Correction Act of 2007; S.2401, False Claims Act Correction Act of 2007.
Shareholder Vote on Executive Compensation Act
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.2, Fair Minimum Wage Act of 2007; H.R.976, Children's Health Insurance Program Reauthorization Act of 2007; H.R.1257, Shareholder Vote on Executive Compensation Act; H.R.4854, False Claims Act Correction Act of 2007; S.2401, False Claims Act Correction Act of 2007. Legislative proposals regarding shareholder participation in corporate executive compensation decisons: H.R.2, Fair Minimum Wage Act of 2007; H.R.976, Children's Health Insurance Program Reauthorization Act of 2007; H.R.1257, Shareholder Vote on Executive Compensation Act. Legislation to amend the Federal False Claims Act: H.R.4854, False Claims Act Correction Act of 2007; S.2401, False Claims Act Correction Act of 2007.
Shareholder Vote on Executive Compensation Act
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.2, Fair Minimum Wage Act of 2007; H.R.976, Children's Health Insurance Program Reauthorization Act of 2007; H.R.1257, Shareholder Vote on Executive Compensation Act; H.R.4854, False Claims Act Correction Act of 2007; S.2401, False Claims Act Correction Act of 2007. Legislative proposals regarding shareholder participation in corporate executive compensation decisons: H.R.2, Fair Minimum Wage Act of 2007; H.R.976, Children's Health Insurance Program Reauthorization Act of 2007; H.R.1257, Shareholder Vote on Executive Compensation Act. Legislation to amend the Federal False Claims Act: H.R.4854, False Claims Act Correction Act of 2007; S.2401, False Claims Act Correction Act of 2007.
Shareholder Vote on Executive Compensation Act
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.2, Fair Minimum Wage Act of 2007; H.R.976, Children's Health Insurance Program Reauthorization Act of 2007; H.R.1257, Shareholder Vote on Executive Compensation Act; H.R.4854, False Claims Act Correction Act of 2007; S.2401, False Claims Act Correction Act of 2007. Legislative proposals regarding shareholder participation in corporate executive compensation decisons: H.R.2, Fair Minimum Wage Act of 2007; H.R.976, Children's Health Insurance Program Reauthorization Act of 2007; H.R.1257, Shareholder Vote on Executive Compensation Act. Legislation to amend the Federal False Claims Act: H.R.4854, False Claims Act Correction Act of 2007; S.2401, False Claims Act Correction Act of 2007.
Patent Reform Act of 2007
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1038, Access to Life-Saving Medicine Act; H.R.1908, Patent Reform Act of 2007; H.R.5629, Pathway for Biosimilars Act; S.316, Preserve Access to Affordable Generics Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1145, Patent Reform Act of 2007; S.1505, Affordable Biologics for Consumers Act. Legislative proposals effecting US patent system: H.R.1908, Patent Reform Act of 2007; S.1145, Patent Reform Act of 2007. Legislative proposals regarding follow-on biologics: H.R.1038, Access to Life-Saving Medicine Act; H.R.5629, Pathway for Biosimilars Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1505, Affordable Biologics for Consumers Act. Legislative proposals regarding brand-generic drug firm agreements: S.316, Preserve Access to Affordable Generics Act.
Patent Reform Act of 2007
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1038, Access to Life-Saving Medicine Act; H.R.1908, Patent Reform Act of 2007; H.R.5629, Pathway for Biosimilars Act; S.316, Preserve Access to Affordable Generics Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1145, Patent Reform Act of 2007; S.1505, Affordable Biologics for Consumers Act. Legislative proposals effecting US patent system: H.R.1908, Patent Reform Act of 2007; S.1145, Patent Reform Act of 2007. Legislative proposals regarding follow-on biologics: H.R.1038, Access to Life-Saving Medicine Act; H.R.5629, Pathway for Biosimilars Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1505, Affordable Biologics for Consumers Act. Legislative proposals regarding brand-generic drug firm agreements: S.316, Preserve Access to Affordable Generics Act.
Patent Reform Act of 2007
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1038, Access to Life-Saving Medicine Act; H.R.1908, Patent Reform Act of 2007; H.R.5629, Pathway for Biosimilars Act; S.316, Preserve Access to Affordable Generics Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1145, Patent Reform Act of 2007; S.1505, Affordable Biologics for Consumers Act; S.3463, A bill to amend the trade Act of 1974; S.3600, A bill to amend Title 35 US Code. Legislative proposals effecting US patent system: H.R.1908, Patent Reform Act of 2007; S.1145, Patent Reform Act of 2007; S.3463, A bill to amend the Trade Act of 1974 to improve the international protection and enforcement of intellectual property rights, and for other purposes; S.3600, A bill to amend title 35 US Code, to provide for patent reforms. Legislative proposals regarding follow-on biologics: H.R.1038, Access to Life-Saving Medicine Act; H.R.5629, Pathway for Biosimilars Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1505, Affordable Biologics for Consumers Act. Legislative proposals regarding brand-generic drug firm agreements: S.316, Preserve Access to Affordable Generics Act.
Patent Reform Act of 2007
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1038, Access to Life-Saving Medicine Act; H.R.1908, Patent Reform Act of 2007; H.R.5629, Pathway for Biosimilars Act; S.316, Preserve Access to Affordable Generics Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1145, Patent Reform Act of 2007; S.1505, Affordable Biologics for Consumers Act. Legislative proposals effecting US patent system: H.R.1908, Patent Reform Act of 2007; S.1145, Patent Reform Act of 2007. Legislative proposals regarding follow-on biologics: H.R.1038, Access to Life-Saving Medicine Act; H.R.5629, Pathway for Biosimilars Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1505, Affordable Biologics for Consumers Act. Legislative proposals regarding brand-generic drug firm agreements: S.316, Preserve Access to Affordable Generics Act.
Food and Drug Administration Amendments Act of 2007
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1585, National Defense Authorization Act for Fiscal Year 2008; H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.2900, Food and Drug Administration Amendments Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; H.R.4083, Non-prescription Drug Modernization Act od 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.2331, Non-prescription Drug Modernization Act of 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legisaltive proposals to extend federal contract prices to the retail section in the TRICARE program: H.R.1585, National Defense Authorization Act for Fiscal Year 2008; S.1547, National Defense Authorization Act for Fiscal Year 2008. Legilsative proposals permitting importation of prescription drugs from overseas: H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.1082, Food and Drug Administration Revitalization Act; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legislative proposals regarding drug safety, clinical trial registries, DTC adverstising, and reauthorization of the Prescription Drug User Fee Act, Best Pharmaceuticals for Children Act and Pediatric Research Equity Act: H.R.2900, Food and Drug Administration Amendments Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008. Legislative proposals regarding FDA funding: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative proposals to ensure access to meth-safe alternative medicines: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development , Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative propsals to reform the OTC monograph system: H.R.4083, Non-prescription Drug Modernization Act of 2007; S.2331, Non-prescription Drug Modernization Act of 2007. Response to congressional investigation regarding ENHANCE study.
Food and Drug Administration Amendments Act of 2007
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1585, National Defense Authorization Act for Fiscal Year 2008; H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.2900, Food and Drug Administration Amendments Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; H.R.4083, Non-prescription Drug Modernization Act od 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.2331, Non-prescription Drug Modernization Act of 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legisaltive proposals to extend federal contract prices to the retail section in the TRICARE program: H.R.1585, National Defense Authorization Act for Fiscal Year 2008; S.1547, National Defense Authorization Act for Fiscal Year 2008. Legilsative proposals permitting importation of prescription drugs from overseas: H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.1082, Food and Drug Administration Revitalization Act; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legislative proposals regarding drug safety, clinical trial registries, DTC adverstising, and reauthorization of the Prescription Drug User Fee Act, Best Pharmaceuticals for Children Act and Pediatric Research Equity Act: H.R.2900, Food and Drug Administration Amendments Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008. Legislative proposals regarding FDA funding: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative proposals to ensure access to meth-safe alternative medicines: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development , Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative propsals to reform the OTC monograph system: H.R.4083, Non-prescription Drug Modernization Act of 2007; S.2331, Non-prescription Drug Modernization Act of 2007. Response to congressional investigation regarding ENHANCE study.
Food and Drug Administration Amendments Act of 2007
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1585, National Defense Authorization Act for Fiscal Year 2008; H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.2900, Food and Drug Administration Amendments Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; H.R.4083, Non-prescription Drug Modernization Act od 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.2331, Non-prescription Drug Modernization Act of 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legisaltive proposals to extend federal contract prices to the retail section in the TRICARE program: H.R.1585, National Defense Authorization Act for Fiscal Year 2008; S.1547, National Defense Authorization Act for Fiscal Year 2008. Legilsative proposals permitting importation of prescription drugs from overseas: H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.1082, Food and Drug Administration Revitalization Act; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legislative proposals regarding drug safety, clinical trial registries, DTC adverstising, and reauthorization of the Prescription Drug User Fee Act, Best Pharmaceuticals for Children Act and Pediatric Research Equity Act: H.R.2900, Food and Drug Administration Amendments Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008. Legislative proposals regarding FDA funding: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative proposals to ensure access to meth-safe alternative medicines: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development , Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative propsals to reform the OTC monograph system: H.R.4083, Non-prescription Drug Modernization Act of 2007; S.2331, Non-prescription Drug Modernization Act of 2007. Response to congressional investigation regarding ENHANCE study.
Food and Drug Administration Amendments Act of 2007
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1585, National Defense Authorization Act for Fiscal Year 2008; H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.2900, Food and Drug Administration Amendments Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; H.R.4083, Non-prescription Drug Modernization Act od 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.2331, Non-prescription Drug Modernization Act of 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legisaltive proposals to extend federal contract prices to the retail section in the TRICARE program: H.R.1585, National Defense Authorization Act for Fiscal Year 2008; S.1547, National Defense Authorization Act for Fiscal Year 2008. Legilsative proposals permitting importation of prescription drugs from overseas: H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.1082, Food and Drug Administration Revitalization Act; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legislative proposals regarding drug safety, clinical trial registries, DTC adverstising, and reauthorization of the Prescription Drug User Fee Act, Best Pharmaceuticals for Children Act and Pediatric Research Equity Act: H.R.2900, Food and Drug Administration Amendments Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008. Legislative proposals regarding FDA funding: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative proposals to ensure access to meth-safe alternative medicines: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development , Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative propsals to reform the OTC monograph system: H.R.4083, Non-prescription Drug Modernization Act of 2007; S.2331, Non-prescription Drug Modernization Act of 2007. Response to congressional investigation regarding ENHANCE study.
Medicare Prescription Drug Price Negotiation Act of 2007
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.4, Medicare Prescription Drug Price Negotiation Act of 2007; H.R.3162, Children's Health and Medicare Protection Act of 2007; S.3, Medicare Prescription Drug Price Negotiation Act of 2007; S.250, Medicare Enhancements for Needed Drugs Act of 2007; S.965,U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act, 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legislative proposals to repeal Medicare "non-interference" provisions: H.R.4, Medicare Prescription Drug Price Negotiation Act of 2007; S.3, Medicare Prescription Drug Price Negotiation Act of 2007; S.250, Medicare Enhancements for Needed Drugs Act of 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legislative proposals effecting Medicaid "average manufactureres' price" AMP: H.R.3162, Children's Health and Medicare Protection Act of 2007; S.965,U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act, 2007.
Medicare Prescription Drug Price Negotiation Act of 2007
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.4, Medicare Prescription Drug Price Negotiation Act of 2007; H.R.3162, Children's Health and Medicare Protection Act of 2007; S.3, Medicare Prescription Drug Price Negotiation Act of 2007; S.250, Medicare Enhancements for Needed Drugs Act of 2007; S.965,U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act, 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legislative proposals to repeal Medicare "non-interference" provisions: H.R.4, Medicare Prescription Drug Price Negotiation Act of 2007; S.3, Medicare Prescription Drug Price Negotiation Act of 2007; S.250, Medicare Enhancements for Needed Drugs Act of 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legislative proposals effecting Medicaid "average manufactureres' price" AMP: H.R.3162, Children's Health and Medicare Protection Act of 2007; S.965,U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act, 2007.
Medicare Prescription Drug Price Negotiation Act of 2007
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.4, Medicare Prescription Drug Price Negotiation Act of 2007; H.R.3162, Children's Health and Medicare Protection Act of 2007; S.3, Medicare Prescription Drug Price Negotiation Act of 2007; S.250, Medicare Enhancements for Needed Drugs Act of 2007; S.965,U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act, 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legislative proposals to repeal Medicare "non-interference" provisions: H.R.4, Medicare Prescription Drug Price Negotiation Act of 2007; S.3, Medicare Prescription Drug Price Negotiation Act of 2007; S.250, Medicare Enhancements for Needed Drugs Act of 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legislative proposals effecting Medicaid "average manufactureres' price" AMP: H.R.3162, Children's Health and Medicare Protection Act of 2007; S.965,U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act, 2007.
Medicare Prescription Drug Price Negotiation Act of 2007
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.4, Medicare Prescription Drug Price Negotiation Act of 2007; H.R.3162, Children's Health and Medicare Protection Act of 2007; S.3, Medicare Prescription Drug Price Negotiation Act of 2007; S.250, Medicare Enhancements for Needed Drugs Act of 2007; S.965,U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act, 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legislative proposals to repeal Medicare "non-interference" provisions: H.R.4, Medicare Prescription Drug Price Negotiation Act of 2007; S.3, Medicare Prescription Drug Price Negotiation Act of 2007; S.250, Medicare Enhancements for Needed Drugs Act of 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legislative proposals effecting Medicaid "average manufactureres' price" AMP: H.R.3162, Children's Health and Medicare Protection Act of 2007; S.965,U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act, 2007.
Non-Prescription Drug Modernization Act of 2007
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1585, National Defense Authorization Act for Fiscal Year 2008; H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.2900, Food and Drug Administration Amendments Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; H.R.4083, Non-prescription Drug Modernization Act od 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.2331, Non-prescription Drug Modernization Act of 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legisaltive proposals to extend federal contract prices to the retail section in the TRICARE program: H.R.1585, National Defense Authorization Act for Fiscal Year 2008; S.1547, National Defense Authorization Act for Fiscal Year 2008. Legilsative proposals permitting importation of prescription drugs from overseas: H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.1082, Food and Drug Administration Revitalization Act; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legislative proposals regarding drug safety, clinical trial registries, DTC adverstising, and reauthorization of the Prescription Drug User Fee Act, Best Pharmaceuticals for Children Act and Pediatric Research Equity Act: H.R.2900, Food and Drug Administration Amendments Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008. Legislative proposals regarding FDA funding: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative proposals to ensure access to meth-safe alternative medicines: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development , Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative propsals to reform the OTC monograph system: H.R.4083, Non-prescription Drug Modernization Act of 2007; S.2331, Non-prescription Drug Modernization Act of 2007. Response to congressional investigation regarding ENHANCE study.
Non-Prescription Drug Modernization Act of 2007
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1585, National Defense Authorization Act for Fiscal Year 2008; H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.2900, Food and Drug Administration Amendments Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; H.R.4083, Non-prescription Drug Modernization Act od 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.2331, Non-prescription Drug Modernization Act of 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legisaltive proposals to extend federal contract prices to the retail section in the TRICARE program: H.R.1585, National Defense Authorization Act for Fiscal Year 2008; S.1547, National Defense Authorization Act for Fiscal Year 2008. Legilsative proposals permitting importation of prescription drugs from overseas: H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.1082, Food and Drug Administration Revitalization Act; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legislative proposals regarding drug safety, clinical trial registries, DTC adverstising, and reauthorization of the Prescription Drug User Fee Act, Best Pharmaceuticals for Children Act and Pediatric Research Equity Act: H.R.2900, Food and Drug Administration Amendments Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008. Legislative proposals regarding FDA funding: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative proposals to ensure access to meth-safe alternative medicines: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development , Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative propsals to reform the OTC monograph system: H.R.4083, Non-prescription Drug Modernization Act of 2007; S.2331, Non-prescription Drug Modernization Act of 2007. Response to congressional investigation regarding ENHANCE study.
Non-Prescription Drug Modernization Act of 2007
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1585, National Defense Authorization Act for Fiscal Year 2008; H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.2900, Food and Drug Administration Amendments Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; H.R.4083, Non-prescription Drug Modernization Act od 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.2331, Non-prescription Drug Modernization Act of 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legisaltive proposals to extend federal contract prices to the retail section in the TRICARE program: H.R.1585, National Defense Authorization Act for Fiscal Year 2008; S.1547, National Defense Authorization Act for Fiscal Year 2008. Legilsative proposals permitting importation of prescription drugs from overseas: H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.1082, Food and Drug Administration Revitalization Act; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legislative proposals regarding drug safety, clinical trial registries, DTC adverstising, and reauthorization of the Prescription Drug User Fee Act, Best Pharmaceuticals for Children Act and Pediatric Research Equity Act: H.R.2900, Food and Drug Administration Amendments Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008. Legislative proposals regarding FDA funding: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative proposals to ensure access to meth-safe alternative medicines: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development , Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative propsals to reform the OTC monograph system: H.R.4083, Non-prescription Drug Modernization Act of 2007; S.2331, Non-prescription Drug Modernization Act of 2007. Response to congressional investigation regarding ENHANCE study.
Non-Prescription Drug Modernization Act of 2007
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1585, National Defense Authorization Act for Fiscal Year 2008; H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.2900, Food and Drug Administration Amendments Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; H.R.4083, Non-prescription Drug Modernization Act od 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.2331, Non-prescription Drug Modernization Act of 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legisaltive proposals to extend federal contract prices to the retail section in the TRICARE program: H.R.1585, National Defense Authorization Act for Fiscal Year 2008; S.1547, National Defense Authorization Act for Fiscal Year 2008. Legilsative proposals permitting importation of prescription drugs from overseas: H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.1082, Food and Drug Administration Revitalization Act; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legislative proposals regarding drug safety, clinical trial registries, DTC adverstising, and reauthorization of the Prescription Drug User Fee Act, Best Pharmaceuticals for Children Act and Pediatric Research Equity Act: H.R.2900, Food and Drug Administration Amendments Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008. Legislative proposals regarding FDA funding: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative proposals to ensure access to meth-safe alternative medicines: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development , Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative propsals to reform the OTC monograph system: H.R.4083, Non-prescription Drug Modernization Act of 2007; S.2331, Non-prescription Drug Modernization Act of 2007. Response to congressional investigation regarding ENHANCE study.
False Claims Act Correction Act of 2007
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.2, Fair Minimum Wage Act of 2007; H.R.976, Children's Health Insurance Program Reauthorization Act of 2007; H.R.1257, Shareholder Vote on Executive Compensation Act; H.R.4854, False Claims Act Correction Act of 2007; S.2401, False Claims Act Correction Act of 2007. Legislative proposals regarding shareholder participation in corporate executive compensation decisons: H.R.2, Fair Minimum Wage Act of 2007; H.R.976, Children's Health Insurance Program Reauthorization Act of 2007; H.R.1257, Shareholder Vote on Executive Compensation Act. Legislation to amend the Federal False Claims Act: H.R.4854, False Claims Act Correction Act of 2007; S.2401, False Claims Act Correction Act of 2007.
False Claims Act Correction Act of 2007
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.2, Fair Minimum Wage Act of 2007; H.R.976, Children's Health Insurance Program Reauthorization Act of 2007; H.R.1257, Shareholder Vote on Executive Compensation Act; H.R.4854, False Claims Act Correction Act of 2007; S.2401, False Claims Act Correction Act of 2007. Legislative proposals regarding shareholder participation in corporate executive compensation decisons: H.R.2, Fair Minimum Wage Act of 2007; H.R.976, Children's Health Insurance Program Reauthorization Act of 2007; H.R.1257, Shareholder Vote on Executive Compensation Act. Legislation to amend the Federal False Claims Act: H.R.4854, False Claims Act Correction Act of 2007; S.2401, False Claims Act Correction Act of 2007.
False Claims Act Correction Act of 2007
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.2, Fair Minimum Wage Act of 2007; H.R.976, Children's Health Insurance Program Reauthorization Act of 2007; H.R.1257, Shareholder Vote on Executive Compensation Act; H.R.4854, False Claims Act Correction Act of 2007; S.2401, False Claims Act Correction Act of 2007. Legislative proposals regarding shareholder participation in corporate executive compensation decisons: H.R.2, Fair Minimum Wage Act of 2007; H.R.976, Children's Health Insurance Program Reauthorization Act of 2007; H.R.1257, Shareholder Vote on Executive Compensation Act. Legislation to amend the Federal False Claims Act: H.R.4854, False Claims Act Correction Act of 2007; S.2401, False Claims Act Correction Act of 2007.
False Claims Act Correction Act of 2007
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.2, Fair Minimum Wage Act of 2007; H.R.976, Children's Health Insurance Program Reauthorization Act of 2007; H.R.1257, Shareholder Vote on Executive Compensation Act; H.R.4854, False Claims Act Correction Act of 2007; S.2401, False Claims Act Correction Act of 2007. Legislative proposals regarding shareholder participation in corporate executive compensation decisons: H.R.2, Fair Minimum Wage Act of 2007; H.R.976, Children's Health Insurance Program Reauthorization Act of 2007; H.R.1257, Shareholder Vote on Executive Compensation Act. Legislation to amend the Federal False Claims Act: H.R.4854, False Claims Act Correction Act of 2007; S.2401, False Claims Act Correction Act of 2007.
Pathway for Biosimilars Act
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1038, Access to Life-Saving Medicine Act; H.R.1908, Patent Reform Act of 2007; H.R.5629, Pathway for Biosimilars Act; S.316, Preserve Access to Affordable Generics Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1145, Patent Reform Act of 2007; S.1505, Affordable Biologics for Consumers Act; S.3463, A bill to amend the trade Act of 1974; S.3600, A bill to amend Title 35 US Code. Legislative proposals effecting US patent system: H.R.1908, Patent Reform Act of 2007; S.1145, Patent Reform Act of 2007; S.3463, A bill to amend the Trade Act of 1974 to improve the international protection and enforcement of intellectual property rights, and for other purposes; S.3600, A bill to amend title 35 US Code, to provide for patent reforms. Legislative proposals regarding follow-on biologics: H.R.1038, Access to Life-Saving Medicine Act; H.R.5629, Pathway for Biosimilars Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1505, Affordable Biologics for Consumers Act. Legislative proposals regarding brand-generic drug firm agreements: S.316, Preserve Access to Affordable Generics Act.
Pathway for Biosimilars Act
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1038, Access to Life-Saving Medicine Act; H.R.1908, Patent Reform Act of 2007; H.R.5629, Pathway for Biosimilars Act; S.316, Preserve Access to Affordable Generics Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1145, Patent Reform Act of 2007; S.1505, Affordable Biologics for Consumers Act. Legislative proposals effecting US patent system: H.R.1908, Patent Reform Act of 2007; S.1145, Patent Reform Act of 2007. Legislative proposals regarding follow-on biologics: H.R.1038, Access to Life-Saving Medicine Act; H.R.5629, Pathway for Biosimilars Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1505, Affordable Biologics for Consumers Act. Legislative proposals regarding brand-generic drug firm agreements: S.316, Preserve Access to Affordable Generics Act.
Pathway for Biosimilars Act
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1038, Access to Life-Saving Medicine Act; H.R.1908, Patent Reform Act of 2007; H.R.5629, Pathway for Biosimilars Act; S.316, Preserve Access to Affordable Generics Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1145, Patent Reform Act of 2007; S.1505, Affordable Biologics for Consumers Act. Legislative proposals effecting US patent system: H.R.1908, Patent Reform Act of 2007; S.1145, Patent Reform Act of 2007. Legislative proposals regarding follow-on biologics: H.R.1038, Access to Life-Saving Medicine Act; H.R.5629, Pathway for Biosimilars Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1505, Affordable Biologics for Consumers Act. Legislative proposals regarding brand-generic drug firm agreements: S.316, Preserve Access to Affordable Generics Act.
Pathway for Biosimilars Act
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1038, Access to Life-Saving Medicine Act; H.R.1908, Patent Reform Act of 2007; H.R.5629, Pathway for Biosimilars Act; S.316, Preserve Access to Affordable Generics Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1145, Patent Reform Act of 2007; S.1505, Affordable Biologics for Consumers Act. Legislative proposals effecting US patent system: H.R.1908, Patent Reform Act of 2007; S.1145, Patent Reform Act of 2007. Legislative proposals regarding follow-on biologics: H.R.1038, Access to Life-Saving Medicine Act; H.R.5629, Pathway for Biosimilars Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1505, Affordable Biologics for Consumers Act. Legislative proposals regarding brand-generic drug firm agreements: S.316, Preserve Access to Affordable Generics Act.
To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the animal drug user fee program, to establish a program of fees relating to generic new animal drugs, to make certain technical corrections to the Food and Drug Administration Amendments Act of 2007, and for other purposes.
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.2419, Farm, Nutrition, and Bioenergy Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.6432, To amend the Federal Food, Drug, and Cosmetic Act; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative proposals regarding national animal ID program and country of origin labeling: H.R.2419, Farm, Nutrition, and Bioenergy Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.6432, To amend the Federal Food, Drug, and Cosmetic Act to revise and extend animal drug user fee program, to establish a program of fees relating to generic new animal drugs, to make certain technical corrections to the Food and Drug Administration Amendments Act of 2007, and for other purposes; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008.
Patent Reform Act of 2007
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1038, Access to Life-Saving Medicine Act; H.R.1908, Patent Reform Act of 2007; H.R.5629, Pathway for Biosimilars Act; S.316, Preserve Access to Affordable Generics Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1145, Patent Reform Act of 2007; S.1505, Affordable Biologics for Consumers Act. Legislative proposals effecting US patent system: H.R.1908, Patent Reform Act of 2007; S.1145, Patent Reform Act of 2007. Legislative proposals regarding follow-on biologics: H.R.1038, Access to Life-Saving Medicine Act; H.R.5629, Pathway for Biosimilars Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1505, Affordable Biologics for Consumers Act. Legislative proposals regarding brand-generic drug firm agreements: S.316, Preserve Access to Affordable Generics Act.
Patent Reform Act of 2007
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1038, Access to Life-Saving Medicine Act; H.R.1908, Patent Reform Act of 2007; H.R.5629, Pathway for Biosimilars Act; S.316, Preserve Access to Affordable Generics Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1145, Patent Reform Act of 2007; S.1505, Affordable Biologics for Consumers Act. Legislative proposals effecting US patent system: H.R.1908, Patent Reform Act of 2007; S.1145, Patent Reform Act of 2007. Legislative proposals regarding follow-on biologics: H.R.1038, Access to Life-Saving Medicine Act; H.R.5629, Pathway for Biosimilars Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1505, Affordable Biologics for Consumers Act. Legislative proposals regarding brand-generic drug firm agreements: S.316, Preserve Access to Affordable Generics Act.
Patent Reform Act of 2007
Client: SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
H.R.1038, Access to Life-Saving Medicine Act; H.R.1908, Patent Reform Act of 2007; H.R.5629, Pathway for Biosimilars Act; S.316, Preserve Access to Affordable Generics Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1145, Patent Reform Act of 2007; S.1505, Affordable Biologics for Consumers Act; S.3463, A bill to amend the trade Act of 1974; S.3600, A bill to amend Title 35 US Code. Legislative proposals effecting US patent system: H.R.1908, Patent Reform Act of 2007; S.1145, Patent Reform Act of 2007; S.3463, A bill to amend the Trade Act of 1974 to improve the international protection and enforcement of intellectual property rights, and for other purposes; S.3600, A bill to amend title 35 US Code, to provide for patent reforms. Legislative proposals regarding follow-on biologics: H.R.1038, Access to Life-Saving Medicine Act; H.R.5629, Pathway for Biosimilars Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1505, Affordable Biologics for Consumers Act. Legislative proposals regarding brand-generic drug firm agreements: S.316, Preserve Access to Affordable Generics Act.
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009. Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009. Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009. Response to congressional investigation regarding ENHANCE study.
H.R.2, Children's Health Insurance Program Reauthorization Act of 2009.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C via SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
2009 · third_quarter · 3T
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
S.260. Legislative proposals regarding taxation of income of US corporations earned overseas: S.260.
H.R.2, Children's Health Insurance Program Reauthorization Act of 2009.
H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009. Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009. Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009. Response to congressional investigation regarding ENHANCE study.
Legislative proposals that would incrase the Medicaid drug price rebate. (none yet introduced in this Congress)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C via SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
2009 · third_quarter · Q3
Legislative proposals that would incrase the Medicaid drug price rebate. (none yet introduced in this Congress)
S.260. Legislative proposals regarding taxation of income of US corporations earned overseas: S.260.
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009. Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009. Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009. Response to congressional investigation regarding ENHANCE study.
H.R.2, Children's Health Insurance Program Reauthorization Act of 2009.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C via SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
2009 · second_quarter · Q2
H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009. Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009. Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009. Response to congressional investigation regarding ENHANCE study.
S.260. Legislative proposals regarding taxation of income of US corporations earned overseas: S.260.
H.R.2, Children's Health Insurance Program Reauthorization Act of 2009.
Legislative proposals that would increase the Medicaid drug price rebate. (none yet introduced in this Congress)
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C via SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
2009 · first_quarter · Q1
H.R.2, Children's Health Insurance Program Reauthorization Act of 2009.
Legislative proposals that would incrase the Medicaid drug price rebate. (none yet introduced in this Congress)
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009. Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009. Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009. Response to congressional investigation regarding ENHANCE study.
S.260. Legislative proposals regarding taxation of income of US corporations earned overseas: S.260.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C via SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
2008 · fourth_quarter · Q4
H.R.4, Medicare Prescription Drug Price Negotiation Act of 2007; H.R.3162, Children's Health and Medicare Protection Act of 2007; S.3, Medicare Prescription Drug Price Negotiation Act of 2007; S.250, Medicare Enhancements for Needed Drugs Act of 2007; S.965,U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act, 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legislative proposals to repeal Medicare "non-interference" provisions: H.R.4, Medicare Prescription Drug Price Negotiation Act of 2007; S.3, Medicare Prescription Drug Price Negotiation Act of 2007; S.250, Medicare Enhancements for Needed Drugs Act of 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legislative proposals effecting Medicaid "average manufactureres' price" AMP: H.R.3162, Children's Health and Medicare Protection Act of 2007; S.965,U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act, 2007.
SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C via SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
2008 · third_quarter · Q3
H.R.1038, Access to Life-Saving Medicine Act; H.R.1908, Patent Reform Act of 2007; H.R.5629, Pathway for Biosimilars Act; S.316, Preserve Access to Affordable Generics Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1145, Patent Reform Act of 2007; S.1505, Affordable Biologics for Consumers Act. Legislative proposals effecting US patent system: H.R.1908, Patent Reform Act of 2007; S.1145, Patent Reform Act of 2007. Legislative proposals regarding follow-on biologics: H.R.1038, Access to Life-Saving Medicine Act; H.R.5629, Pathway for Biosimilars Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1505, Affordable Biologics for Consumers Act. Legislative proposals regarding brand-generic drug firm agreements: S.316, Preserve Access to Affordable Generics Act.
H.R.2419, Farm, Nutrition, and Bioenergy Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative proposals regarding national animal ID program and country of origin labeling: H.R.2419, Farm, Nutrition, and Bioenergy Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008.
SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C via SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
2008 · second_quarter · Q2
H.R.1585, National Defense Authorization Act for Fiscal Year 2008; H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.2900, Food and Drug Administration Amendments Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; H.R.4083, Non-prescription Drug Modernization Act od 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.2331, Non-prescription Drug Modernization Act of 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legisaltive proposals to extend federal contract prices to the retail section in the TRICARE program: H.R.1585, National Defense Authorization Act for Fiscal Year 2008; S.1547, National Defense Authorization Act for Fiscal Year 2008. Legilsative proposals permitting importation of prescription drugs from overseas: H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.1082, Food and Drug Administration Revitalization Act; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legislative proposals regarding drug safety, clinical trial registries, DTC adverstising, and reauthorization of the Prescription Drug User Fee Act, Best Pharmaceuticals for Children Act and Pediatric Research Equity Act: H.R.2900, Food and Drug Administration Amendments Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008. Legislative proposals regarding FDA funding: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative proposals to ensure access to meth-safe alternative medicines: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development , Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative propsals to reform the OTC monograph system: H.R.4083, Non-prescription Drug Modernization Act of 2007; S.2331, Non-prescription Drug Modernization Act of 2007. Response to congressional investigation regarding ENHANCE study.
SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C via SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
2008 · first_quarter · Q1
H.R.2, Fair Minimum Wage Act of 2007; H.R.976, Children's Health Insurance Program Reauthorization Act of 2007; H.R.1257, Shareholder Vote on Executive Compensation Act; H.R.4854, False Claims Act Correction Act of 2007; S.2401, False Claims Act Correction Act of 2007. Legislative proposals regarding shareholder participation in corporate executive compensation decisons: H.R.2, Fair Minimum Wage Act of 2007; H.R.976, Children's Health Insurance Program Reauthorization Act of 2007; H.R.1257, Shareholder Vote on Executive Compensation Act. Legislation to amend the Federal False Claims Act: H.R.4854, False Claims Act Correction Act of 2007; S.2401, False Claims Act Correction Act of 2007.
H.R.1038, Access to Life-Saving Medicine Act; H.R.1908, Patent Reform Act of 2007; H.R.5629, Pathway for Biosimilars Act; S.316, Preserve Access to Affordable Generics Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1145, Patent Reform Act of 2007; S.1505, Affordable Biologics for Consumers Act. Legislative proposals effecting US patent system: H.R.1908, Patent Reform Act of 2007; S.1145, Patent Reform Act of 2007. Legislative proposals regarding follow-on biologics: H.R.1038, Access to Life-Saving Medicine Act; H.R.5629, Pathway for Biosimilars Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1505, Affordable Biologics for Consumers Act. Legislative proposals regarding brand-generic drug firm agreements: S.316, Preserve Access to Affordable Generics Act.
SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C via SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
2007 · year_end · YY
Legislative proposals regarding shareholder participation in corporate executive compensation decisions: H.R.2, Fair Minimum Wage Act of 2007; H.R.976, Children's Health Insurance Program Reauthorization Act of 2007; H.R.1257, Shareholder Vote on Executive Compensation Act. H.R.2, Fair Minimum Wage Act of 2007; H.R.976, Children's Health Insurance Program Reauthorization Act of 2007; H.R.1257, Shareholder Vote on Executive Compensation Act.
Legislative proposals regarding national animal ID program and country of origin labeling: H.R.2419, Farm, Nutrition, and Bioenergy Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008. H.R.2419, Farm, Nutrition, and Bioenergy Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008.
SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C via SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
2007 · mid_year · MM
S.965,U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act, 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legislative proposals to repeal Medicare "non-interference" provisions: H.R.4, Medicare Prescription Drug Price Negotiation Act of 2007; S.3, Medicare Prescription Drug Price Negotiation Act of 2007; S.250, Medicare Enhancements for Needed Drugs Act of 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legislative proposals effecting Medicaid "average manufactureres' price" AMP: H.R.3162, Children's Health and Medicare Protection Act of 2007; S.965,U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act, 2007. H.R.4, Medicare Prescription Drug Price Negotiation Act of 2007; H.R.3162, Children's Health and Medicare Protection Act of 2007; S.3, Medicare Prescription Drug Price Negotiation Act of 2007; S.250, Medicare Enhancements for Needed Drugs Act of 2007;
SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C via SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
2006 · year_end · YA
Legislation regarding pandemic vaccine production: H.R.3970, Bioterror Pandemic Preparedness Protection Act; H.R.4062, Pandemic Preparedness Response Act; H.R.4603, Pandemic Seasonal Influenza Act of 2005; S.1437, Bioterror Pandemic Preparedness Protection Act;S.1821, Pandemic Preparedness Response Act; S.1873, Biodefense Pandemic Vaccine Drug Development Act of 2005; S.1880, National Biodefense Pandemic Preparedness Act of 2005. Preserve Access to Affordable Drugs Act of 2005; S.873, Medicare Prescription drug Savings and Choice Act of 2005; S.930, Food and Drug Administration Safety Act of 2005. Legislation controlling access to precursor chemicals for meth production and/or combating meth: H.R.1056, Methamphetamine Precursor Control Act of 2005; H.R.13, Clean, Learn, Educate, Abolish, Neutralize, and Undermine Production (CLEAN-UP) of Methamphetamine Act; H.R.1350, Methamphetamine Blister Pack Loophole Elimination Act of 2005; H.R.2335, Meth-Endangered Children Protection Act of 2005; H.R.313, Exile Meth Act; H.R.314, Combat Meth Act of 2005; H.R.3199, Patient Act H.R.1572, Preserving Access to Affordable Drugs Act of 2005; H.R.1626, Medicare Prescription Drug Improvement Act; H.R.1669, Pharmacy Benefit Manager Transparency Act of 2005; H.R.328, Pharmaceutical Market Access Act of 2005; H.R.417, Medical Innovation Prize Act of 2005; H.R.4660, Requiring Emergency Pharmaceutical Access for Individual Relief (REPAIR) Act of 2006; H.R.4663, Authorize the Secretary of HHS to Reimburse States for Expenditures Associated with the Implementation of the Medicare Prescription Drug Benefit for Dual Eligible Individuals; H.R.4665, Amend Title XIX of the Social Security Act to Provide for an Offset from the Medicaid Clawback for State Emergency Prescription Drug Expenditures for Medicare Dual-Eligible Individuals; H.R.4675, Medicare State Reimbursement Act of 2006; H.R.4685, Medicare Prescription Drug Emergency Guarantee Act of 2006; H.R.4715, Amend Title XVIII of the Social Secruity Act to Estend the 2006 Annual Coordinated Election Period for Medicare Prescription Drug Plans through August 15, 2006; H.R.4719, Patients Before Profits Act of 2006; H.R.4721, Require Secretary of HHS To Provide Federal Medicaid for State Costs Associated with Ensuring Access to Prescription Drug Benefits to Part D Eligible Individuals; H.R.700, Pharmaceutical Market Access and Drug Safety Act of 2005; H.R.752, Medicare Prescription Drug Savings and Choice Act of 2005; H.R.870, Pharmaceutical research and Manufacturers Accountability Act of 2005, PhRMA Act of 2005; S.109, Pharmaceutical Market Access Act of 2005; S.1128, Pharmaceutical Advertising and Prudent Purchasing Act; S.334, Pharmaceutical Market Access and Drug Safety Act of 2005; S.354, HEALTH Act of 2005, Health Efficient, Accessible, Low-Cost, timely Healthcare Act of 2005; S.764, Preserve Access to Affordable Drugs Act of 2005; S.873, Medicare Prescription drug Savings and Choice Act of 2005; S.930, Food and Drug Administration Safety Act of 2005. Methamphetamine Precursor Control Act of 2005; H.R.13, Clean, Learn, Educate, Abolish, Neutralize, and Undermine Production (CLEAN-UP) of Methamphetamine Act; H.R.1350, Methamphetamine Blister Pack Loophole Elimination Act of 2005; H.R.152, Preserving Access to Affordable Drugs Act of 2005; H.R.1572, Preserving Access to Affordable Drugs Act of 2005; H.R.1626, Medicare Prescription Drug Improvement Act; H.R.1669, Pharmacy Benefit Manager Transparency Act of 2005; H.R.2335, Meth-Endangered Children Protection Act of 2005; H.R.313, Exile Meth Act; H.R.314, Combat Meth Act of 2005; H.R.3199, Patient Act Reauthorization; H.R.328, Pharmaceutical Market Access Act of 2005; H.R.3324, Arrest Methamphetamine Act of 2005; H.R.3889, The Methamphetamine Elimination Act; H.R.3970, Bioterror Pandemic Preparedness Protection Act; H.R.4062, Pandemic Preparedness Response Act; H.R.4603, Pandemic Seasonal Influenza Act of 2005; H.R.4660, Requiring Emergency Pharmaceutical Access for Individual Relief (REPAIR) Act of 2006; H.R.4663, Authorize the Secretary of HHS to Reimburse States for Expenditures Associated with the Implementation of the Medicare Prescription Drug Benefit for Dual Eligible Individuals; H.R.4665, Amend Title XIX of the Social Security Act to Provide for an Offset from the Medicaid Clawback for State Emergency Prescription Drug Expenditures for Medicare Dual-Eligible Individuals; H.R.4675, Medicare State Reimbursement Act of 2006; H.R.4685, Medicare Prescription Drug Emergency Guarantee Act of 2006; H.R.4715, Amend Title XVIII of the Social Secruity Act to Estend the 2006 Annual Coordinated Election Period for Medicare Prescription Drug Plans through August 15, 2006; H.R.4719, Patients Before Profits Act of 2006; H.R.4721, Require Secretary of HHS To Provide Federal Medicaid for State Costs Associated with Ensuring Access to Prescription Drug Benefits to Part D Eligible Individuals; H.R.700, Pharmaceutical Market Access and Drug Safety Act of 2005; H.R.417, Medical Innovation Prize Act of 2005; H.R.752, Medicare Prescription Drug Savings and Choice Act of 2005; H.R.798, Methamphetamine Remediation Act of 2005; H.R.870, Pharmaceutical research and Manufacturers Accountability Act of 2005, PhRMA Act of 2005; S.103, Combat Meth Act of 2005; S.109, Pharmaceutical Market Access Act of 2005; S.1128, Pharmaceutical Advertising and Prudent Purchasing Act; S.1361, A bill to amend the Controlled Substances Act to treat drug offenses involving crystal meth similarly to drug offenses involving crack cocaine; S.1437, Bioterror Pandemic Preparedness Protection Act; S.1821, Pandemic Preparedness Response Act; S.1873, Biodefense Pandemic Vaccine Drug Development Act of 2005; S.1880, National Biodefense Pandemic Preparedness Act of 2005; S.334, Pharmaceutical Market Access and Drug Safety Act of 2005; S.354, HEALTH Act of 2005, Health Efficient, Accessible, Low-Cost, timely Healthcare Act of 2005; S.764, H.CON.RES.75, Expressing the sense of the congress that the illegal importation of prescription drugs severely undermines the regulatory protections afforded to the United States consumers, and for other purposes; H.R.1056,
SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C via SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
2006 · mid_year · MA
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C via SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
2006 · year_end · YY
Legislation regarding duty suspension for Ezetimibe: H.R.2077, To suspend temporarily the duty on Garenoxacin mesylate; H.R.2079, To extend the temporary duty suspension on Ezetimibe; S.1551, Protecting Free Trade in Pharmaceuticals Act of 2005. H.R.2077, To suspend temporarily the duty on Garenoxacin mesylate; H.R.2079, To extend the temporary duty suspension on Ezetimibe; S.1551, Protecting Free Trade in Pharmaceuticals Act of 2005.
Legislative proposals to implement and fund a national identification system, and/or country of origin labeling: H.R.1254, National Farm Animal Identifiction and Records Act; H.R. 3170, To establish a Livestock Identification Board to create and implement a mandatory national livestock identification. Legislative proposals to affect US frequency standards for animal micro-chips: H.R.2744, Fiscal 2006 Agriculture Appropriations. H.R.1254, National Farm Animal Identification and Records Act; H.R.2744, Fiscal 2006 Agriculture Appropriations; H.R.3170, To establish a Livestock Identification Board to create and implement a mandatory national livestock identification system.
SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C via SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
2005 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C via SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
2005 · mid_year · MA
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C via SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
2005 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C via SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
2004 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C via SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
2004 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C via SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
2003 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C via SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
2003 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C via SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
2003 · mid_year · RA
SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C via SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.
2002 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R.1038, Access to Life-Saving Medicine Act; H.R.1908, Patent Reform Act of 2007; H.R.5629, Pathway for Biosimilars Act; S.316, Preserve Access to Affordable Generics Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1145, Patent Reform Act of 2007; S.1505, Affordable Biologics for Consumers Act; S.3463, A bill to amend the trade Act of 1974; S.3600, A bill to amend Title 35 US Code. Legislative proposals effecting US patent system: H.R.1908, Patent Reform Act of 2007; S.1145, Patent Reform Act of 2007; S.3463, A bill to amend the Trade Act of 1974 to improve the international protection and enforcement of intellectual property rights, and for other purposes; S.3600, A bill to amend title 35 US Code, to provide for patent reforms. Legislative proposals regarding follow-on biologics: H.R.1038, Access to Life-Saving Medicine Act; H.R.5629, Pathway for Biosimilars Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1505, Affordable Biologics for Consumers Act. Legislative proposals regarding brand-generic drug firm agreements: S.316, Preserve Access to Affordable Generics Act.
H.R.2419, Farm, Nutrition, and Bioenergy Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.6432, To amend the Federal Food, Drug, and Cosmetic Act; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative proposals regarding national animal ID program and country of origin labeling: H.R.2419, Farm, Nutrition, and Bioenergy Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.6432, To amend the Federal Food, Drug, and Cosmetic Act to revise and extend animal drug user fee program, to establish a program of fees relating to generic new animal drugs, to make certain technical corrections to the Food and Drug Administration Amendments Act of 2007, and for other purposes; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008.
H.R.1585, National Defense Authorization Act for Fiscal Year 2008; H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.2900, Food and Drug Administration Amendments Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; H.R.4083, Non-prescription Drug Modernization Act od 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.2331, Non-prescription Drug Modernization Act of 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legisaltive proposals to extend federal contract prices to the retail section in the TRICARE program: H.R.1585, National Defense Authorization Act for Fiscal Year 2008; S.1547, National Defense Authorization Act for Fiscal Year 2008. Legilsative proposals permitting importation of prescription drugs from overseas: H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.1082, Food and Drug Administration Revitalization Act; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legislative proposals regarding drug safety, clinical trial registries, DTC adverstising, and reauthorization of the Prescription Drug User Fee Act, Best Pharmaceuticals for Children Act and Pediatric Research Equity Act: H.R.2900, Food and Drug Administration Amendments Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008. Legislative proposals regarding FDA funding: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative proposals to ensure access to meth-safe alternative medicines: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development , Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative propsals to reform the OTC monograph system: H.R.4083, Non-prescription Drug Modernization Act of 2007; S.2331, Non-prescription Drug Modernization Act of 2007. Response to congressional investigation regarding ENHANCE study.
H.R.2, Fair Minimum Wage Act of 2007; H.R.976, Children's Health Insurance Program Reauthorization Act of 2007; H.R.1257, Shareholder Vote on Executive Compensation Act; H.R.4854, False Claims Act Correction Act of 2007; S.2401, False Claims Act Correction Act of 2007. Legislative proposals regarding shareholder participation in corporate executive compensation decisons: H.R.2, Fair Minimum Wage Act of 2007; H.R.976, Children's Health Insurance Program Reauthorization Act of 2007; H.R.1257, Shareholder Vote on Executive Compensation Act. Legislation to amend the Federal False Claims Act: H.R.4854, False Claims Act Correction Act of 2007; S.2401, False Claims Act Correction Act of 2007.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R.1585, National Defense Authorization Act for Fiscal Year 2008; H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.2900, Food and Drug Administration Amendments Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; H.R.4083, Non-prescription Drug Modernization Act od 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.2331, Non-prescription Drug Modernization Act of 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legisaltive proposals to extend federal contract prices to the retail section in the TRICARE program: H.R.1585, National Defense Authorization Act for Fiscal Year 2008; S.1547, National Defense Authorization Act for Fiscal Year 2008. Legilsative proposals permitting importation of prescription drugs from overseas: H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.1082, Food and Drug Administration Revitalization Act; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legislative proposals regarding drug safety, clinical trial registries, DTC adverstising, and reauthorization of the Prescription Drug User Fee Act, Best Pharmaceuticals for Children Act and Pediatric Research Equity Act: H.R.2900, Food and Drug Administration Amendments Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008. Legislative proposals regarding FDA funding: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative proposals to ensure access to meth-safe alternative medicines: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development , Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative propsals to reform the OTC monograph system: H.R.4083, Non-prescription Drug Modernization Act of 2007; S.2331, Non-prescription Drug Modernization Act of 2007. Response to congressional investigation regarding ENHANCE study.
H.R.2, Fair Minimum Wage Act of 2007; H.R.976, Children's Health Insurance Program Reauthorization Act of 2007; H.R.1257, Shareholder Vote on Executive Compensation Act; H.R.4854, False Claims Act Correction Act of 2007; S.2401, False Claims Act Correction Act of 2007. Legislative proposals regarding shareholder participation in corporate executive compensation decisons: H.R.2, Fair Minimum Wage Act of 2007; H.R.976, Children's Health Insurance Program Reauthorization Act of 2007; H.R.1257, Shareholder Vote on Executive Compensation Act. Legislation to amend the Federal False Claims Act: H.R.4854, False Claims Act Correction Act of 2007; S.2401, False Claims Act Correction Act of 2007.
H.R.4, Medicare Prescription Drug Price Negotiation Act of 2007; H.R.3162, Children's Health and Medicare Protection Act of 2007; S.3, Medicare Prescription Drug Price Negotiation Act of 2007; S.250, Medicare Enhancements for Needed Drugs Act of 2007; S.965,U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act, 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legislative proposals to repeal Medicare "non-interference" provisions: H.R.4, Medicare Prescription Drug Price Negotiation Act of 2007; S.3, Medicare Prescription Drug Price Negotiation Act of 2007; S.250, Medicare Enhancements for Needed Drugs Act of 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legislative proposals effecting Medicaid "average manufactureres' price" AMP: H.R.3162, Children's Health and Medicare Protection Act of 2007; S.965,U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act, 2007.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R.2419, Farm, Nutrition, and Bioenergy Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative proposals regarding national animal ID program and country of origin labeling: H.R.2419, Farm, Nutrition, and Bioenergy Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008.
H.R.4, Medicare Prescription Drug Price Negotiation Act of 2007; H.R.3162, Children's Health and Medicare Protection Act of 2007; S.3, Medicare Prescription Drug Price Negotiation Act of 2007; S.250, Medicare Enhancements for Needed Drugs Act of 2007; S.965,U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act, 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legislative proposals to repeal Medicare "non-interference" provisions: H.R.4, Medicare Prescription Drug Price Negotiation Act of 2007; S.3, Medicare Prescription Drug Price Negotiation Act of 2007; S.250, Medicare Enhancements for Needed Drugs Act of 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legislative proposals effecting Medicaid "average manufactureres' price" AMP: H.R.3162, Children's Health and Medicare Protection Act of 2007; S.965,U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act, 2007.
H.R.2, Fair Minimum Wage Act of 2007; H.R.976, Children's Health Insurance Program Reauthorization Act of 2007; H.R.1257, Shareholder Vote on Executive Compensation Act; H.R.4854, False Claims Act Correction Act of 2007; S.2401, False Claims Act Correction Act of 2007. Legislative proposals regarding shareholder participation in corporate executive compensation decisons: H.R.2, Fair Minimum Wage Act of 2007; H.R.976, Children's Health Insurance Program Reauthorization Act of 2007; H.R.1257, Shareholder Vote on Executive Compensation Act. Legislation to amend the Federal False Claims Act: H.R.4854, False Claims Act Correction Act of 2007; S.2401, False Claims Act Correction Act of 2007.
H.R.1038, Access to Life-Saving Medicine Act; H.R.1908, Patent Reform Act of 2007; H.R.5629, Pathway for Biosimilars Act; S.316, Preserve Access to Affordable Generics Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1145, Patent Reform Act of 2007; S.1505, Affordable Biologics for Consumers Act. Legislative proposals effecting US patent system: H.R.1908, Patent Reform Act of 2007; S.1145, Patent Reform Act of 2007. Legislative proposals regarding follow-on biologics: H.R.1038, Access to Life-Saving Medicine Act; H.R.5629, Pathway for Biosimilars Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1505, Affordable Biologics for Consumers Act. Legislative proposals regarding brand-generic drug firm agreements: S.316, Preserve Access to Affordable Generics Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R.1585, National Defense Authorization Act for Fiscal Year 2008; H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.2900, Food and Drug Administration Amendments Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; H.R.4083, Non-prescription Drug Modernization Act od 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.2331, Non-prescription Drug Modernization Act of 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legisaltive proposals to extend federal contract prices to the retail section in the TRICARE program: H.R.1585, National Defense Authorization Act for Fiscal Year 2008; S.1547, National Defense Authorization Act for Fiscal Year 2008. Legilsative proposals permitting importation of prescription drugs from overseas: H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.1082, Food and Drug Administration Revitalization Act; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legislative proposals regarding drug safety, clinical trial registries, DTC adverstising, and reauthorization of the Prescription Drug User Fee Act, Best Pharmaceuticals for Children Act and Pediatric Research Equity Act: H.R.2900, Food and Drug Administration Amendments Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008. Legislative proposals regarding FDA funding: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative proposals to ensure access to meth-safe alternative medicines: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development , Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative propsals to reform the OTC monograph system: H.R.4083, Non-prescription Drug Modernization Act of 2007; S.2331, Non-prescription Drug Modernization Act of 2007. Response to congressional investigation regarding ENHANCE study.
H.R.4, Medicare Prescription Drug Price Negotiation Act of 2007; H.R.3162, Children's Health and Medicare Protection Act of 2007; S.3, Medicare Prescription Drug Price Negotiation Act of 2007; S.250, Medicare Enhancements for Needed Drugs Act of 2007; S.965,U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act, 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legislative proposals to repeal Medicare "non-interference" provisions: H.R.4, Medicare Prescription Drug Price Negotiation Act of 2007; S.3, Medicare Prescription Drug Price Negotiation Act of 2007; S.250, Medicare Enhancements for Needed Drugs Act of 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legislative proposals effecting Medicaid "average manufactureres' price" AMP: H.R.3162, Children's Health and Medicare Protection Act of 2007; S.965,U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act, 2007.
H.R.2419, Farm, Nutrition, and Bioenergy Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative proposals regarding national animal ID program and country of origin labeling: H.R.2419, Farm, Nutrition, and Bioenergy Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008.
Legislative proposals effecting US patent system: H.R.1908, Patent Reform Act of 2007; S.1145, Patent Reform Act of 2007. Legislative proposals regarding follow-on biologics: H.R.1038, Access to Life-Saving Medicine Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1505, Affordable Biologics for Consumers Act. Legislative proposals regarding brand-generic drug firm agreements: S.316, Preserve Access to Affordable Generics Act. H.R.1038, Access to Life-Saving Medicine Act; H.R.1908, Patent Reform Act of 2007; S.316, Preserve Access to Affordable Generics Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1145, Patent Reform Act of 2007; S.1505, Affordable Biologics for Consumers Act.
S.965,U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act, 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legislative proposals to repeal Medicare "non-interference" provisions: H.R.4, Medicare Prescription Drug Price Negotiation Act of 2007; S.3, Medicare Prescription Drug Price Negotiation Act of 2007; S.250, Medicare Enhancements for Needed Drugs Act of 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legislative proposals effecting Medicaid "average manufactureres' price" AMP: H.R.3162, Children's Health and Medicare Protection Act of 2007; S.965,U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act, 2007. H.R.4, Medicare Prescription Drug Price Negotiation Act of 2007; H.R.3162, Children's Health and Medicare Protection Act of 2007; S.3, Medicare Prescription Drug Price Negotiation Act of 2007; S.250, Medicare Enhancements for Needed Drugs Act of 2007;
S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.2331, Non-prescription Drug Modernization Act of 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legisaltive proposals to extend federal contract prices to the retail section in the TRICARE program: H.R.1585, National Defense Authorization Act for Fiscal Year 2008; S.1547, National Defense Authorization Act for Fiscal Year 2008. Legilsative proposals permitting importation of prescription drugs from overseas: H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.1082, Food and Drug Administration Revitalization Act; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legislative proposals regarding drug safety, clinical trial registries, DTC adverstising, and reauthorization of the Prescription Drug User Fee Act, Best Pharmaceuticals for Children Act and Pediatric Research Equity Act: H.R.2900, Food and Drug Administration Amendments Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008. Legislative proposals regarding FDA funding: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative proposals to ensure access to meth-safe alternative medicines: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative propsals to reform the OTC monograph system: H.R.4083, Non-prescription Drug Modernization Act of 2007; S.2331, Non-prescription Drug Modernization Act of 2007. Response to congressional investigation regarding ENHANCE study. H.R.1585, National Defense Authorization Act for Fiscal Year 2008; H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.2900, Food and Drug Administration Amendments Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; H.R.4083, Non-prescription Drug Modernization Act od 2007;
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Legislative proposals effecting US patent system: H.R.1908, Patent Reform Act of 2007; S.1145, Patent Reform Act of 2007. Legislative proposals regarding follow-on biologics: H.R.1038, Access to Life-Saving Medicine Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1505, Affordable Biologics for Consumers Act. Legislative proposals regarding brand-generic drug firm agreements: S.316, Preserve Access to Affordable Generics Act. H.R.1038, Access to Life-Saving Medicine Act; H.R.1908, Patent Reform Act of 2007; S.316, Preserve Access to Affordable Generics Act; S.623, Access to Life-Saving Medicine Act; S.1082, Food and Drug Administration Revitalization Act; S.1145, Patent Reform Act of 2007; S.1505, Affordable Biologics for Consumers Act.
Legislative proposals regarding national animal ID program and country of origin labeling: H.R.2419, Farm, Nutrition, and Bioenergy Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008. H.R.2419, Farm, Nutrition, and Bioenergy Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008.
S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legisaltive proposals to extend federal contract prices to the retail section in the TRICARE program: H.R.1585, National Defense Authorization Act for Fiscal Year 2008; S.1547, National Defense Authorization Act for Fiscal Year 2008. Legilsative proposals permitting importation of prescription drugs from overseas: H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.1082, Food and Drug Administration Revitalization Act; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legislative proposals regarding drug safety, clinical trial registries, DTC adverstising, and reauthorization of the Prescription Drug User Fee Act, Best Pharmaceuticals for Children Act and Pediatric Research Equity Act: H.R.2900, Food and Drug Administration Amendments Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008. Legislative proposals regarding FDA funding: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative proposals to ensure access to meth-safe alternative medicines: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008. H.R.1585, National Defense Authorization Act for Fiscal Year 2008; H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.2900, Food and Drug Administration Amendments Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007;
Legislative proposals regarding shareholder participation in corporate executive compensation decisions: H.R.2, Fair Minimum Wage Act of 2007; H.R.976, Children's Health Insurance Program Reauthorization Act of 2007; H.R.1257, Shareholder Vote on Executive Compensation Act. H.R.2, Fair Minimum Wage Act of 2007; H.R.976, Children's Health Insurance Program Reauthorization Act of 2007; H.R.1257, Shareholder Vote on Executive Compensation Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Legislative proposals to ban Medicare and Medicaid reimbursement for erectile dysfunction drugs: H.R.3971, Medicare Cost Sharing and Welfare Extension Act of 2005. Amendments and bill language related to changes in Medicare reimbursement to pharmacies for prescription drugs and changes to Medicaid best price rebate: H.R.4241, Deficit Reduction Act of 2005. H.R.3971, Medicare Cost Sharing and Welfare Extension Act of 2005; H.R.4241, Deficit Reduction Act of 2005.
Legislation regarding duty suspension for Ezetimibe: H.R.2077, To suspend temporarily the duty on Garenoxacin mesylate; H.R.2079, To extend the temporary duty suspension on Ezetimibe; S.1551, Protecting Free Trade in Pharmaceuticals Act of 2005. H.R.2077, To suspend temporarily the duty on Garenoxacin mesylate; H.R.2079, To extend the temporary duty suspension on Ezetimibe; S.1551, Protecting Free Trade in Pharmaceuticals Act of 2005.
Legislative proposals related to a national animal identification program: H.R.1254, National Farm Animal Identification and Records Act; H.R.3170, To establish a Livestock Identification Board to create and implement a mandatory national livestock identification system. H.R.1254, National Farm Animal Identification and Records Act; H.R.3170, To estabish a Livestock Identification Board to create and implement a mandatory national livestock identification system.
Legislative proposals to implement and fund a national identification system, and/or country of origin labeling: H.R.1254, National Farm Animal Identifiction and Records Act; H.R. 3170, To establish a Livestock Identification Board to create and implement a mandatory national livestock identification. Legislative proposals to affect US frequency standards for animal micro-chips: H.R.2744, Fiscal 2006 Agriculture Appropriations. H.R.1254, National Farm Animal Identification and Records Act; H.R.2744, Fiscal 2006 Agriculture Appropriations; H.R.3170, To establish a Livestock Identification Board to create and implement a mandatory national livestock identification system.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Legislative proposals to ban Medicare and Medicaid reimbursement for erectile dysfunction drugs: H.R.3971, Medicare Cost Sharing and Welfare Extension Act of 2005. Amendments and bill language related to changes in Medicare reimbursement to pharmacies for prescription drugs and changes to Medicaid best price rebate: H.R.4241, Deficit Reduction Act of 2005. H.R.3971, Medicare Cost Sharing and Welfare Extension Act of 2005; H.R.4241, Deficit Reduction Act of 2005.
Legislative proposals related to a national animal identification program: H.R.1254, National Farm Animal Identification and Records Act; H.R.3170, To establish a Livestock Identification Board to create and implement a mandatory national livestock identification system. H.R.1254, National Farm Animal Identification and Records Act; H.R.3170, To estabish a Livestock Identification Board to create and implement a mandatory national livestock identification system.
Legislation regarding pandemic vaccine production: H.R.3970, Bioterror Pandemic Preparedness Protection Act; H.R.4062, Pandemic Preparedness Response Act; H.R.4603, Pandemic Seasonal Influenza Act of 2005; S.1437, Bioterror Pandemic Preparedness Protection Act;S.1821, Pandemic Preparedness Response Act; S.1873, Biodefense Pandemic Vaccine Drug Development Act of 2005; S.1880, National Biodefense Pandemic Preparedness Act of 2005. Preserve Access to Affordable Drugs Act of 2005; S.873, Medicare Prescription drug Savings and Choice Act of 2005; S.930, Food and Drug Administration Safety Act of 2005. Legislation controlling access to precursor chemicals for meth production and/or combating meth: H.R.1056, Methamphetamine Precursor Control Act of 2005; H.R.13, Clean, Learn, Educate, Abolish, Neutralize, and Undermine Production (CLEAN-UP) of Methamphetamine Act; H.R.1350, Methamphetamine Blister Pack Loophole Elimination Act of 2005; H.R.2335, Meth-Endangered Children Protection Act of 2005; H.R.313, Exile Meth Act; H.R.314, Combat Meth Act of 2005; H.R.3199, Patient Act H.R.1572, Preserving Access to Affordable Drugs Act of 2005; H.R.1626, Medicare Prescription Drug Improvement Act; H.R.1669, Pharmacy Benefit Manager Transparency Act of 2005; H.R.328, Pharmaceutical Market Access Act of 2005; H.R.417, Medical Innovation Prize Act of 2005; H.R.4660, Requiring Emergency Pharmaceutical Access for Individual Relief (REPAIR) Act of 2006; H.R.4663, Authorize the Secretary of HHS to Reimburse States for Expenditures Associated with the Implementation of the Medicare Prescription Drug Benefit for Dual Eligible Individuals; H.R.4665, Amend Title XIX of the Social Security Act to Provide for an Offset from the Medicaid Clawback for State Emergency Prescription Drug Expenditures for Medicare Dual-Eligible Individuals; H.R.4675, Medicare State Reimbursement Act of 2006; H.R.4685, Medicare Prescription Drug Emergency Guarantee Act of 2006; H.R.4715, Amend Title XVIII of the Social Secruity Act to Estend the 2006 Annual Coordinated Election Period for Medicare Prescription Drug Plans through August 15, 2006; H.R.4719, Patients Before Profits Act of 2006; H.R.4721, Require Secretary of HHS To Provide Federal Medicaid for State Costs Associated with Ensuring Access to Prescription Drug Benefits to Part D Eligible Individuals; H.R.700, Pharmaceutical Market Access and Drug Safety Act of 2005; H.R.752, Medicare Prescription Drug Savings and Choice Act of 2005; H.R.870, Pharmaceutical research and Manufacturers Accountability Act of 2005, PhRMA Act of 2005; S.109, Pharmaceutical Market Access Act of 2005; S.1128, Pharmaceutical Advertising and Prudent Purchasing Act; S.334, Pharmaceutical Market Access and Drug Safety Act of 2005; S.354, HEALTH Act of 2005, Health Efficient, Accessible, Low-Cost, timely Healthcare Act of 2005; S.764, Preserve Access to Affordable Drugs Act of 2005; S.873, Medicare Prescription drug Savings and Choice Act of 2005; S.930, Food and Drug Administration Safety Act of 2005. Methamphetamine Precursor Control Act of 2005; H.R.13, Clean, Learn, Educate, Abolish, Neutralize, and Undermine Production (CLEAN-UP) of Methamphetamine Act; H.R.1350, Methamphetamine Blister Pack Loophole Elimination Act of 2005; H.R.152, Preserving Access to Affordable Drugs Act of 2005; H.R.1572, Preserving Access to Affordable Drugs Act of 2005; H.R.1626, Medicare Prescription Drug Improvement Act; H.R.1669, Pharmacy Benefit Manager Transparency Act of 2005; H.R.2335, Meth-Endangered Children Protection Act of 2005; H.R.313, Exile Meth Act; H.R.314, Combat Meth Act of 2005; H.R.3199, Patient Act Reauthorization; H.R.328, Pharmaceutical Market Access Act of 2005; H.R.3324, Arrest Methamphetamine Act of 2005; H.R.3889, The Methamphetamine Elimination Act; H.R.3970, Bioterror Pandemic Preparedness Protection Act; H.R.4062, Pandemic Preparedness Response Act; H.R.4603, Pandemic Seasonal Influenza Act of 2005; H.R.4660, Requiring Emergency Pharmaceutical Access for Individual Relief (REPAIR) Act of 2006; H.R.4663, Authorize the Secretary of HHS to Reimburse States for Expenditures Associated with the Implementation of the Medicare Prescription Drug Benefit for Dual Eligible Individuals; H.R.4665, Amend Title XIX of the Social Security Act to Provide for an Offset from the Medicaid Clawback for State Emergency Prescription Drug Expenditures for Medicare Dual-Eligible Individuals; H.R.4675, Medicare State Reimbursement Act of 2006; H.R.4685, Medicare Prescription Drug Emergency Guarantee Act of 2006; H.R.4715, Amend Title XVIII of the Social Secruity Act to Estend the 2006 Annual Coordinated Election Period for Medicare Prescription Drug Plans through August 15, 2006; H.R.4719, Patients Before Profits Act of 2006; H.R.4721, Require Secretary of HHS To Provide Federal Medicaid for State Costs Associated with Ensuring Access to Prescription Drug Benefits to Part D Eligible Individuals; H.R.700, Pharmaceutical Market Access and Drug Safety Act of 2005; H.R.417, Medical Innovation Prize Act of 2005; H.R.752, Medicare Prescription Drug Savings and Choice Act of 2005; H.R.798, Methamphetamine Remediation Act of 2005; H.R.870, Pharmaceutical research and Manufacturers Accountability Act of 2005, PhRMA Act of 2005; S.103, Combat Meth Act of 2005; S.109, Pharmaceutical Market Access Act of 2005; S.1128, Pharmaceutical Advertising and Prudent Purchasing Act; S.1361, A bill to amend the Controlled Substances Act to treat drug offenses involving crystal meth similarly to drug offenses involving crack cocaine; S.1437, Bioterror Pandemic Preparedness Protection Act; S.1821, Pandemic Preparedness Response Act; S.1873, Biodefense Pandemic Vaccine Drug Development Act of 2005; S.1880, National Biodefense Pandemic Preparedness Act of 2005; S.334, Pharmaceutical Market Access and Drug Safety Act of 2005; S.354, HEALTH Act of 2005, Health Efficient, Accessible, Low-Cost, timely Healthcare Act of 2005; S.764, H.CON.RES.75, Expressing the sense of the congress that the illegal importation of prescription drugs severely undermines the regulatory protections afforded to the United States consumers, and for other purposes; H.R.1056,
Filing targets: HOUSE OF REPRESENTATIVES, SENATE